|
1
|
Bartel DP: MicroRNAs: genomics,
biogenesis, mechanism, and function. Cell. 116:281–297. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Calin GA, Dumitru CD, Shimizu M, Bichi R,
Zupo S, Noch E, Aldler H, Rattan S, Keating M, Rai K, et al:
Frequent deletions and down-regulation of micro-RNA genes miR15 and
miR16 at 13q14 in chronic lymphocytic leukemia. Proc Natl Acad Sci
USA. 99:15524–15529. 2002. View Article : Google Scholar
|
|
3
|
Calin GA, Sevignani C, Dumitru CD, Hyslop
T, Noch E, Yendamuri S, Shimizu M, Rattan S, Bullrich F, Negrini M
and Croce CM: Human microRNA genes are frequently located at
fragile sites and genomic regions involved in cancers. Proc Natl
Acad Sci USA. 101:2999–3004. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Kawakami K, Enokida H, Chiyomaru T,
Tatarano S, Yoshino H, Kagara I, Gotanda T, Tachiwada T, Nishiyama
K, Nohata N, et al: The functional significance of miR-1 and
miR-133a in renal cell carcinoma. Eur J Cancer. 48:827–836. 2012.
View Article : Google Scholar
|
|
5
|
Nohata N, Hanazawa T, Kikkawa N, Sakurai
D, Sasaki K, Chiyomaru T, Kawakami K, Yoshino H, Enokida H,
Nakagawa M, et al: Identification of novel molecular targets
regulated by tumor suppressive miR-1/miR-133a in maxillary sinus
squamous cell carcinoma. Int J Oncol. 39:1099–1107. 2011.PubMed/NCBI
|
|
6
|
Rao PK, Missiaglia E, Shields L, Hyde G,
Yuan B, Shepherd CJ, Shipley J and Lodish HF: Distinct roles for
miR-1 and miR-133a in the proliferation and differentiation of
rhabdomyosarcoma cells. FASEB J. 24:3427–3437. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Moriya Y, Nohata N, Kinoshita T, Mutallip
M, Okamoto T, Yoshida S, Suzuki M, Yoshino I and Seki N: Tumor
suppressive microRNA-133a regulates novel molecular networks in
lung squamous cell carcinoma. J Hum Genet. 57:38–45. 2012.
View Article : Google Scholar
|
|
8
|
Wong TS, Liu XB, Chung-Wai Ho A, Po-Wing
Yuen A, Wai-Man Ng R and Ignace Wei W: Identification of pyruvate
kinase type M2 as potential oncoprotein in squamous cell carcinoma
of tongue through microRNA profiling. Int J Cancer. 123:251–257.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Kano M, Seki N, Kikkawa N, Fujimura L,
Hoshino I, Akutsu Y, Chiyomaru T, Enokida H, Nakagawa M and
Matsubara H: miR-145, miR-133a and miR-133b: tumor-suppressive
miRNAs target FSCN1 in esophageal squamous cell carcinoma. Int J
Cancer. 127:2804–2814. 2010. View Article : Google Scholar
|
|
10
|
Kojima S, Chiyomaru T, Kawakami K, Yoshino
H, Enokida H, Nohata N, Fuse M, Ichikawa T, Naya Y, Nakagawa M and
Seki N: Tumour suppressors miR-1 and miR-133a target the oncogenic
function of purine nucleoside phosphorylase (PNP) in prostate
cancer. Br J Cancer. 106:405–413. 2012. View Article : Google Scholar :
|
|
11
|
Yoshino H, Chiyomaru T, Enokida H,
Kawakami K, Tatarano S, Nishiyama K, Nohata N, Seki N and Nakagawa
M: The tumour-suppressive function of miR-1 and miR-133a targeting
TAGLN2 in bladder cancer. Br J Cancer. 104:808–818. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Nohata N, Hanazawa T, Kikkawa N, Mutallip
M, Fujimura L, Yoshino H, Kawakami K, Chiyomaru T, Enokida H,
Nakagawa M, et al: Caveolin-1 mediates tumor cell migration and
invasion and its regulation by miR-133a in head and neck squamous
cell carcinoma. Int J Oncol. 38:209–217. 2011.
|
|
13
|
Yoshizawa K, Nozaki S, Kitahara H, Ohara
T, Kato K, Kawashiri S and Yamamoto E: Copper efflux transporter
(ATP7B) contributes to the acquisition of cisplatin-resistance in
human oral squamous cell lines. Oncol Rep. 18:987–991.
2007.PubMed/NCBI
|
|
14
|
Furukawa T, Komatsu M, Ikeda R, Tsujikawa
K and Akiyama S: Copper transport systems are involved in multidrug
resistance and drug transport. Curr Med Chem. 15:3268–3278. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Komatsu M, Sumizawa T, Mutoh M, Chen ZS,
Terada K, Furukawa T, Yang XL, Gao H, Miura N, Sugiyama T and
Akiyama S: Copper-transporting P-type adenosine triphosphatase
(ATP7B) is associated with cisplatin resistance. Cancer Res.
60:1312–1316. 2000.PubMed/NCBI
|
|
16
|
Nakayama K, Kanzaki A, Ogawa K, Miyazaki
K, Neamati N and Takebayashi Y: Copper-transporting P-type
adenosine triphosphatase (ATP7B) as a cisplatin based
chemoresistance marker in ovarian carcinoma: comparative analysis
with expression of MDR1, MRP1, MRP2, LRP and BCRP. Int J Cancer.
101:488–495. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Nakayama K, Miyazaki K, Kanzaki A,
Fukumoto M and Takebayashi Y: Expression and cisplatin sensitivity
of copper-transporting P-type adenosine triphosphatase (ATP7B) in
human solid carcinoma cell lines. Oncol Rep. 8:1285–1287.
2001.PubMed/NCBI
|
|
18
|
Nakamura M, Nakatani K, Uzawa K, Ono K,
Uesugi H, Ogawara K, Shiiba M, Bukawa H, Yokoe H, Wada T, et al:
Establishment and characterization of a cisplatin-resistant oral
squamous cell carcinoma cell line, H-1R. Oncol Rep. 14:1281–1286.
2005.PubMed/NCBI
|
|
19
|
Nakatani K, Nakamura M, Uzawa K, Wada T,
Seki N, Tanzawa H and Fujita S: Establishment and gene analysis of
a cisplatin-resistant cell line, Sa-3R, derived from oral squamous
cell carcinoma. Oncol Rep. 13:709–714. 2005.PubMed/NCBI
|
|
20
|
Yin W, Wang P, Wang X, Song W, Cui X, Yu H
and Zhu W: Identification of microRNAs and mRNAs associated with
multidrug resistance of human laryngeal cancer Hep-2 cells. Braz J
Med Biol Res. 46:546–554. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Petzoldt S, Kahra D, Kovermann M,
Dingeldein AP, Niemiec MS, Ådén J and Wittung-Stafshede P: Human
cytoplasmic copper chaperones Atox1 and CCS exchange copper ions in
vitro. Biometals. 28:577–585. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Wernimont AK, Huffman DL, Lamb AL,
O'Halloran TV and Rosenzweig AC: Structural basis for copper
transfer by the metallochaperone for the Menkes/Wilson disease
proteins. Nat Struct Biol. 7:766–771. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Palm-Espling ME, Lundin C, Björn E, Naredi
P and Wittung-Stafshede P: Interaction between the anticancer drug
Cisplatin and the copper chaperone Atox1 in human melanoma cells.
Protein Pept Lett. 21:63–68. 2014. View Article : Google Scholar
|
|
24
|
Chen ZS, Mutoh M, Sumizawa T, Furukawa T,
Haraguchi M, Tani A, Saijo N, Kondo T and Akiyama S: An active
efflux system for heavy metals in cisplatin-resistant human KB
carcinoma cells. Exp Cell Res. 240:312–320. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Schilsky ML, Stockert RJ, Kesner A, Gorla
GR, Gagliardi GS, Terada K, Miura N and Czaja MJ: Copper resistant
human hepatoblastoma mutant cell lines without metallothionein
induction overexpress ATP7B. Hepatology. 28:1347–1356. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Wang D and Lippard SJ: Cellular processing
of platinum anticancer drugs. Nat Rev Drug Discov. 4:307–320. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Parker RJ, Eastman A, Bostick-Bruton F and
Reed E: Acquired cisplatin resistance in human ovarian cancer cells
is associated with enhanced repair of cisplatin-DNA lesions and
reduced drug accumulation. J Clin Invest. 87:772–777. 1991.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Loh SY, Mistry P, Kelland LR, Abel G and
Harrap KR: Reduced drug accumulation as a major mechanism of
acquired resistance to cisplatin in a human ovarian carcinoma cell
line: circumvention studies using novel platinum (II) and (IV)
ammine/amine complexes. Br J Cancer. 66:1109–1115. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Lai C, Chen Z and Li R: MicroRNA-133a
inhibits proliferation and invasion, and induces apoptosis in
gastric carcinoma cells via targeting fascin actin-bundling protein
1. Mol Med Rep. 12:1473–1478. 2015.PubMed/NCBI
|
|
30
|
Yuan Y, Yao YF, Hu SN, Gao J and Zhang LL:
MiR-133a is functionally involved in doxorubicin-resistance in
breast cancer cells MCF-7 via its regulation of the expression of
uncoupling protein 2. PLoS One. 10:e01298432015. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Chekhun VF, Lukyanova NY, Burlaka CA,
Bezdenezhnykh NA, Shpyleva SI, Tryndyak VP, Beland FA and Pogribny
IP: Iron metabolism disturbances in the MCF-7 human breast cancer
cells with acquired resistance to doxorubicin and cisplatin. Int J
Oncol. 43:1481–1486. 2013.PubMed/NCBI
|
|
32
|
Wang P, Fu T, Wang X and Zhu W: Primary,
study of miRNA expression patterns in laryngeal carcinoma by
microarray. Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi.
24:535–538. 2010.In Chinese. PubMed/NCBI
|
